Covert Medications: Act of Compassion or Conspiracy of Silence?

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

As the population in the United States gets older, more people suffer from dementia, which often causes neuropsychiatric symptoms such as agitation and paranoia. This can lead patients to refuse medications, prompting consideration of covert administration (that is, concealing medication in food or drink). While many condemn this practice as paternalistic, deceptive, and potentially harmful, the end result of assuming the "moral high ground" can be increased suffering for patients and families. This article addresses common criticisms of covert medication and presents a detailed algorithm by which to determine whether the practice is ethically permissible in specific cases. It also explores why so little attention has been paid in the U.S. to this presumably common practice, and reviews professional statements from Europe that endorse the practice. Finally, it presents a compelling argument for the role of Ulysses clauses in advance care planning, not only for patients with psychiatric illness but also for those who may suffer from dementia, which is far more common.

Original languageEnglish (US)
Pages (from-to)298-307
Number of pages10
JournalThe Journal of clinical ethics
Volume27
Issue number4
StatePublished - Dec 1 2016

Fingerprint

medication
act
Dementia
Advance Care Planning
dementia
Paranoid Disorders
Professional Practice
Psychiatry
Food
criticism
illness
food
Population
planning
cause

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health(social science)
  • Health Policy

Cite this

Covert Medications : Act of Compassion or Conspiracy of Silence? / Macauley, Robert.

In: The Journal of clinical ethics, Vol. 27, No. 4, 01.12.2016, p. 298-307.

Research output: Contribution to journalArticle

@article{9e0e0ee1c4204b3e8cd3182c0ba8aaf1,
title = "Covert Medications: Act of Compassion or Conspiracy of Silence?",
abstract = "As the population in the United States gets older, more people suffer from dementia, which often causes neuropsychiatric symptoms such as agitation and paranoia. This can lead patients to refuse medications, prompting consideration of covert administration (that is, concealing medication in food or drink). While many condemn this practice as paternalistic, deceptive, and potentially harmful, the end result of assuming the {"}moral high ground{"} can be increased suffering for patients and families. This article addresses common criticisms of covert medication and presents a detailed algorithm by which to determine whether the practice is ethically permissible in specific cases. It also explores why so little attention has been paid in the U.S. to this presumably common practice, and reviews professional statements from Europe that endorse the practice. Finally, it presents a compelling argument for the role of Ulysses clauses in advance care planning, not only for patients with psychiatric illness but also for those who may suffer from dementia, which is far more common.",
author = "Robert Macauley",
year = "2016",
month = "12",
day = "1",
language = "English (US)",
volume = "27",
pages = "298--307",
journal = "Journal of Clinical Ethics",
issn = "1046-7890",
publisher = "Journal of Clinical Ethics",
number = "4",

}

TY - JOUR

T1 - Covert Medications

T2 - Act of Compassion or Conspiracy of Silence?

AU - Macauley, Robert

PY - 2016/12/1

Y1 - 2016/12/1

N2 - As the population in the United States gets older, more people suffer from dementia, which often causes neuropsychiatric symptoms such as agitation and paranoia. This can lead patients to refuse medications, prompting consideration of covert administration (that is, concealing medication in food or drink). While many condemn this practice as paternalistic, deceptive, and potentially harmful, the end result of assuming the "moral high ground" can be increased suffering for patients and families. This article addresses common criticisms of covert medication and presents a detailed algorithm by which to determine whether the practice is ethically permissible in specific cases. It also explores why so little attention has been paid in the U.S. to this presumably common practice, and reviews professional statements from Europe that endorse the practice. Finally, it presents a compelling argument for the role of Ulysses clauses in advance care planning, not only for patients with psychiatric illness but also for those who may suffer from dementia, which is far more common.

AB - As the population in the United States gets older, more people suffer from dementia, which often causes neuropsychiatric symptoms such as agitation and paranoia. This can lead patients to refuse medications, prompting consideration of covert administration (that is, concealing medication in food or drink). While many condemn this practice as paternalistic, deceptive, and potentially harmful, the end result of assuming the "moral high ground" can be increased suffering for patients and families. This article addresses common criticisms of covert medication and presents a detailed algorithm by which to determine whether the practice is ethically permissible in specific cases. It also explores why so little attention has been paid in the U.S. to this presumably common practice, and reviews professional statements from Europe that endorse the practice. Finally, it presents a compelling argument for the role of Ulysses clauses in advance care planning, not only for patients with psychiatric illness but also for those who may suffer from dementia, which is far more common.

UR - http://www.scopus.com/inward/record.url?scp=85041690126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041690126&partnerID=8YFLogxK

M3 - Article

C2 - 28001137

AN - SCOPUS:85041690126

VL - 27

SP - 298

EP - 307

JO - Journal of Clinical Ethics

JF - Journal of Clinical Ethics

SN - 1046-7890

IS - 4

ER -